Published in Eur Radiol on December 04, 2011
Image guided biodistribution and pharmacokinetic studies of theranostics. Theranostics (2012) 1.14
Radiologic evaluation of nonalcoholic fatty liver disease. World J Gastroenterol (2014) 1.10
Risk factors for fatty liver in the Multicenter AIDS Cohort Study. Am J Gastroenterol (2014) 1.06
Low vitamin D status is associated with nonalcoholic Fatty liver disease independent of visceral obesity in Korean adults. PLoS One (2013) 0.92
Hepatic steatosis is associated with lower incidence of liver metastasis from colorectal cancer. Int J Colorectal Dis (2013) 0.88
Importance of imaging and recent developments in diagnosis of nonalcoholic fatty liver disease. World J Hepatol (2015) 0.86
Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment. Clin Mol Hepatol (2016) 0.82
Longitudinal Changes in Liver Fat Content in Asymptomatic Adults: Hepatic Attenuation on Unenhanced CT as an Imaging Biomarker for Steatosis. AJR Am J Roentgenol (2015) 0.80
Liver steatosis and the risk of albuminuria: the multi-ethnic study of atherosclerosis. J Nephrol (2015) 0.78
Quantification of hepatic and visceral fat by CT and MR imaging: relevance to the obesity epidemic, metabolic syndrome and NAFLD. Br J Radiol (2016) 0.77
Quantitative Imaging Biomarkers of NAFLD. Dig Dis Sci (2016) 0.76
Hypodense liver lesions in patients with hepatic steatosis: do we profit from dual-energy computed tomography? Eur Radiol (2015) 0.75
Non-invasive imaging techniques in assessing non-alcoholic fatty liver disease: a current status of available methods. J Med Life (2017) 0.75
Assessment of liver fat in an obese patient population using noncontrast CT fat percent index. Clin Imaging (2014) 0.75
Virtual iron concentration imaging based on dual-energy CT for noninvasive quantification and grading of liver iron content: An iron overload rabbit model study. Eur Radiol (2015) 0.75
Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology (2005) 29.57
Nonalcoholic fatty liver disease. N Engl J Med (2002) 22.41
Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology (2004) 18.86
The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology (2005) 15.74
Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol (1999) 14.07
Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology (2006) 10.05
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology (2003) 9.36
The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol (2003) 8.23
The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology (2002) 5.70
Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology (1999) 4.14
The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology (1995) 3.73
Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol (2007) 3.45
Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology (2009) 3.31
Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol (2008) 3.23
Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study. Am J Gastroenterol (2008) 3.16
Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology (2011) 3.08
Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology (2006) 3.02
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management. Hepatology (2009) 2.92
Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. J Hepatol (2008) 2.87
Clinical hepatology: profile of an urban, hospital-based practice. Hepatology (1996) 2.56
T(1) independent, T(2) (*) corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis. J Magn Reson Imaging (2011) 2.27
Long term prognosis of fatty liver: risk of chronic liver disease and death. Gut (2004) 2.15
Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol (2006) 2.02
Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology (2004) 1.80
Fatty liver in liver transplantation and surgery. Semin Liver Dis (2001) 1.79
Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease. J Hepatol (2008) 1.67
Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease. Radiology (1980) 1.63
Liver fat is reproducibly measured using computed tomography in the Framingham Heart Study. J Gastroenterol Hepatol (2008) 1.62
Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations. J Hepatol (2010) 1.61
Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance? Hepatology (2010) 1.60
Focal fatty infiltration of the liver: analysis of prevalence and CT findings in children and young adults. AJR Am J Roentgenol (2001) 1.59
Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT. AJR Am J Roentgenol (2010) 1.55
Interobserver and intraobserver variability in the sonographic assessment of fatty liver. AJR Am J Roentgenol (2007) 1.48
Multi-detector row CT attenuation measurements: assessment of intra- and interscanner variability with an anthropomorphic body CT phantom. Radiology (2007) 1.40
Accuracy of computed tomography in diagnosis of fatty liver. Br Med J (1980) 1.32
Liver histology in a 'normal' population--examinations of 503 consecutive fatal traffic casualties. Scand J Gastroenterol (1977) 1.31
Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index. Radiology (2007) 1.30
Computed tomography features of nonalcoholic steatohepatitis with histopathologic correlation. J Comput Assist Tomogr (2005) 1.13
Diagnosing steatohepatitis and predicting liver-related mortality in patients with NAFLD: two distinct concepts. Hepatology (2011) 1.12
Quantification of liver fat in the presence of iron and iodine: an ex-vivo dual-energy CT study. Invest Radiol (2011) 1.02
Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection. Liver Int (2011) 0.97
Hemochromatosis: genetic or alcohol-induced? Gastroenterology (1983) 0.94
Contrast-enhanced computed tomography for the diagnosis of fatty liver: prospective study with same-day biopsy used as the reference standard. Eur Radiol (2009) 0.90
Noninvasive estimation of hepatic steatosis using plain CT vs. chemical-shift MR imaging: significance for living donors. J Magn Reson Imaging (2008) 0.89
Interphantom and interscanner variations for Hounsfield units--establishment of reference values for HU in a commercial QA phantom. Phys Med Biol (2010) 0.88
Prognostic value of abdominal CT scanning and hepatic histopathology in patients with acute liver failure. Dig Dis Sci (2000) 0.86
Biopsy-proven nonsteatotic liver in adults: estimation of reference range for difference in attenuation between the liver and the spleen at nonenhanced CT. Radiology (2011) 0.86
Multiecho MR imaging and proton MR spectroscopy for liver fat quantification. Radiology (2008) 0.81
Fulminant hepatic failure in children: etiology, histopathology and MDCT findings. Eur J Radiol (2008) 0.75
Volume progression in polycystic kidney disease. N Engl J Med (2006) 7.16
Blood pressure in early autosomal dominant polycystic kidney disease. N Engl J Med (2014) 5.01
Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort. Kidney Int (2003) 4.84
Low-dose abdominal CT for evaluating suspected appendicitis. N Engl J Med (2012) 3.71
Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology (2006) 3.02
Lessons learned from 1,000 living donor liver transplantations in a single center: how to make living donations safe. Liver Transpl (2006) 2.58
Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (2006) 2.21
Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity. Sci Transl Med (2011) 2.14
Living donor liver transplantation: the Asian perspective. Transplantation (2014) 2.13
Multiple gastrointestinal stromal tumors: Clinicopathologic and genetic analysis of 12 patients. Am J Surg Pathol (2007) 2.02
Total and intraabdominal fat distribution in preadolescents and adolescents: measurement with MR imaging. Radiology (2007) 1.92
Crohn disease of the small bowel: comparison of CT enterography, MR enterography, and small-bowel follow-through as diagnostic techniques. Radiology (2009) 1.81
Noninvasive diagnostic criteria for hepatocellular carcinoma in hepatic masses >2 cm in a hepatitis B virus-endemic area. Liver Int (2011) 1.77
Granulocytic sarcoma of bowel: CT findings. Radiology (2007) 1.76
Reappraisal of percutaneous transhepatic biliary drainage tract recurrence after resection of perihilar bile duct cancer. World J Surg (2012) 1.73
Restoration of portal flow using a pericholedochal varix in adult living donor liver transplantation for patients with total portosplenomesenteric thrombosis. Liver Transpl (2014) 1.66
Differential renal function estimation using computerized tomography based renal parenchymal volume measurement. J Urol (2010) 1.62
Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations. J Hepatol (2010) 1.61
Salvage living donor liver transplantation after prior liver resection for hepatocellular carcinoma. Liver Transpl (2007) 1.59
The HALT polycystic kidney disease trials: design and implementation. Clin J Am Soc Nephrol (2010) 1.59
Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1/TSC2 contiguous gene syndrome. Kidney Int (2008) 1.58
Donor selection for procurement of right posterior segment graft in living donor liver transplantation. Liver Transpl (2004) 1.56
CT colonography for combined colonic and extracolonic surveillance after curative resection of colorectal cancer. Radiology (2010) 1.54
Volumetric measurement of synthetic lung nodules with multi-detector row CT: effect of various image reconstruction parameters and segmentation thresholds on measurement accuracy. Radiology (2005) 1.54
Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol (2006) 1.53
Characteristics and management of splenic artery aneurysms in adult living donor liver transplant recipients. Liver Transpl (2009) 1.52
Liver transplantation for hepatocellular carcinoma. Ann Surg Oncol (2008) 1.50
Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP). Am J Kidney Dis (2005) 1.49
Exchange living donor liver transplantation to overcome ABO incompatibility in adult patients. Liver Transpl (2010) 1.46
Coronary artery calcium: accuracy and reproducibility of measurements with multi-detector row CT--assessment of effects of different thresholds and quantification methods. Radiology (2003) 1.45
Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease. Kidney Int (2003) 1.45
Improved outcomes in liver transplantation in children with acute liver failure. J Pediatr Gastroenterol Nutr (2014) 1.45
Clinical value of APACHE scores in patients who require intensive care before liver transplantation. Hepatogastroenterology (2009) 1.45
Long-term prognosis of the jejunal involvement of Crohn's disease. J Clin Gastroenterol (2013) 1.45
Automated matching of pulmonary nodules: evaluation in serial screening chest CT. AJR Am J Roentgenol (2009) 1.44
Gastrointestinal metastasis from primary lung cancer: CT findings and clinicopathologic features. AJR Am J Roentgenol (2009) 1.42
The effect of donor weight reduction on hepatic steatosis for living donor liver transplantation. Liver Transpl (2004) 1.41
Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 Study. Am J Kidney Dis (2011) 1.39
[Clinical outcome after living donor liver transplantation in patients with hepatitis C virus-associated cirrhosis]. Korean J Hepatol (2007) 1.38
Validation of CT dose-reduction simulation. Med Phys (2009) 1.38
Comparison of methods for determining renal function decline in early autosomal dominant polycystic kidney disease: the consortium of radiologic imaging studies of polycystic kidney disease cohort. J Am Soc Nephrol (2006) 1.37
Malignant hepatic tumors: short-term reproducibility of apparent diffusion coefficients with breath-hold and respiratory-triggered diffusion-weighted MR imaging. Radiology (2010) 1.36
Computer-aided diagnosis of localized ground-glass opacity in the lung at CT: initial experience. Radiology (2005) 1.36
Sequential transcatheter arterial chemoembolization and portal vein embolization versus portal vein embolization only before major hepatectomy for patients with hepatocellular carcinoma. Ann Surg Oncol (2010) 1.35
A case of primary paraganglioma that arose in the pancreas: the Color Doppler ultrasonography and dynamic CT features. Korean J Radiol (2008) 1.33
Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging--preliminary observations. Radiology (2011) 1.31
Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index. Radiology (2007) 1.30
Crystal structure of the Shank PDZ-ligand complex reveals a class I PDZ interaction and a novel PDZ-PDZ dimerization. J Biol Chem (2003) 1.29
Sequential preoperative ipsilateral hepatic vein embolization after portal vein embolization to induce further liver regeneration in patients with hepatobiliary malignancy. Ann Surg (2009) 1.29
Effect of monitor luminance and ambient light on observer performance in soft-copy reading of digital chest radiographs. Radiology (2004) 1.28
Focal fatty replacement of the pancreas: usefulness of chemical shift MRI. AJR Am J Roentgenol (2007) 1.27
Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations. Liver Transpl (2005) 1.27
Effects of CT section thickness and reconstruction kernel on emphysema quantification relationship to the magnitude of the CT emphysema index. Acad Radiol (2010) 1.26
Crystal structure of GRIP1 PDZ6-peptide complex reveals the structural basis for class II PDZ target recognition and PDZ domain-mediated multimerization. J Biol Chem (2002) 1.25
Antioxidant effects of fermented red ginseng extracts in streptozotocin- induced diabetic rats. J Ginseng Res (2011) 1.25
Imaging features to distinguish malignant and benign branch-duct type intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis. Ann Surg (2014) 1.23
Hepatectomy of living donors with a left-sided gallbladder and multiple combined anomalies for adult-to-adult living donor liver transplantation. Liver Transpl (2004) 1.21
Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol (2010) 1.21
Surgical experience of 204 cases of adult choledochal cyst disease over 14 years. World J Surg (2011) 1.18
Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations. Radiology (2010) 1.18
How to demonstrate similarity by using noninferiority and equivalence statistical testing in radiology research. Radiology (2013) 1.18
Diagnosis of hepatic steatosis and fibrosis by transient elastography in asymptomatic healthy individuals: a prospective study of living related potential liver donors. J Gastroenterol (2007) 1.17
Living-donor liver transplantation: 12 years of experience in Asia. Transplantation (2003) 1.16
Evidence of extraordinary growth in the progressive enlargement of renal cysts. Clin J Am Soc Nephrol (2010) 1.16
Quantitative analysis of diffusion-weighted magnetic resonance imaging of the pancreas: usefulness in characterizing solid pancreatic masses. J Magn Reson Imaging (2008) 1.15
Xanthogranulomatous cholecystitis: diagnostic performance of CT to differentiate from gallbladder cancer. Eur J Radiol (2009) 1.14
Five-year follow-up of a hepatitis B virus-positive recipient of hepatitis B surface antigen-positive living donor liver graft. Liver Transpl (2006) 1.14
Primary leiomyosarcoma of the pulmonary artery: a diagnostic dilemma. Clin Imaging (2003) 1.14
Oncological and surgical results of laparoscopic versus open liver resection for HCC less than 5 cm: case-matched analysis. Surg Endosc (2014) 1.14
A prospective comparison of standard-dose CT enterography and 50% reduced-dose CT enterography with and without noise reduction for evaluating Crohn disease. AJR Am J Roentgenol (2011) 1.13
Torsion of the gallbladder: report of a case. Yonsei Med J (2005) 1.13
Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric study. PLoS One (2013) 1.12
Hepatic fat quantification: a prospective comparison of magnetic resonance spectroscopy and analysis methods for chemical-shift gradient echo magnetic resonance imaging with histologic assessment as the reference standard. Invest Radiol (2012) 1.11
Comparison of standard- and low-radiation-dose CT for quantification of emphysema. AJR Am J Roentgenol (2007) 1.10
Solitary fibrous tumor of the pancreas: imaging findings. Korean J Radiol (2008) 1.09
The Impact of Tumor Size on Long-Term Survival Outcomes After Resection of Solitary Hepatocellular Carcinoma: Single-Institution Experience with 2558 Patients. J Gastrointest Surg (2015) 1.09
Computerized scheme for assessing ultrasonographic features of breast masses. Acad Radiol (2005) 1.09
Obstructive jaundice in hepatocellular carcinoma: response after percutaneous transhepatic biliary drainage and prognostic factors. Cardiovasc Intervent Radiol (2002) 1.08
Surgical outcomes of hepatocellular carcinoma with bile duct tumor thrombus: a Korean multicenter study. World J Surg (2013) 1.08
Diffusion-weighted MR enterography for evaluating Crohn's disease: how does it add diagnostically to conventional MR enterography? Inflamm Bowel Dis (2015) 1.08
Gastrointestinal stromal tumors of the stomach: CT findings and prediction of malignancy. AJR Am J Roentgenol (2004) 1.08
Hepatic hemangiomas with arterioportal shunt: sonographic appearances with CT and MRI correlation. AJR Am J Roentgenol (2006) 1.08
Radiofrequency ablation for recurrent intrahepatic cholangiocarcinoma after curative resection. Eur J Radiol (2010) 1.07
Coronary artery calcification and risk factors for atherosclerosis in patients with venous thromboembolism. Atherosclerosis (2005) 1.07
Usability of ringed polytetrafluoroethylene grafts for middle hepatic vein reconstruction during living donor liver transplantation. Liver Transpl (2012) 1.07
Unusual mesenchymal liver tumors in adults: radiologic-pathologic correlation. AJR Am J Roentgenol (2006) 1.06
Liver transplantation for HCC: its role: Eastern and Western perspectives. J Hepatobiliary Pancreat Sci (2009) 1.06
Long-term incidence, risk factors, and management of biliary complications after adult living donor liver transplantation. Liver Transpl (2006) 1.06
Appendiceal diverticulitis: diagnosis and differentiation from usual acute appendicitis using computed tomography. J Comput Assist Tomogr (2007) 1.06
Single-session treatment of benign cystic thyroid nodules with ethanol versus radiofrequency ablation: a prospective randomized study. Radiology (2013) 1.05
Sorafenib for recurrent hepatocellular carcinoma after liver transplantation. Jpn J Clin Oncol (2010) 1.05
Preoperative detection of prostate cancer: a comparison with 11C-choline PET, 18F-fluorodeoxyglucose PET and MR imaging. J Magn Reson Imaging (2010) 1.02